ID   FA2H_RAT                Reviewed;         372 AA.
AC   Q2LAM0;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   29-MAY-2024, entry version 112.
DE   RecName: Full=Fatty acid 2-hydroxylase {ECO:0000303|PubMed:17901466};
DE            EC=1.14.18.- {ECO:0000250|UniProtKB:Q7L5A8, ECO:0000305|PubMed:17901466};
DE   AltName: Full=Fatty acid alpha-hydroxylase {ECO:0000303|PubMed:17901466};
GN   Name=Fa2h {ECO:0000303|PubMed:17901466, ECO:0000312|RGD:1310347};
GN   Synonyms=Faah;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-347.
RC   STRAIN=Wistar;
RA   Molto E., Bonzon-Kulichenko E., Gallardo N., Andres A.;
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 254-372.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=16998236; DOI=10.1194/jlr.m600362-jlr200;
RA   Alderson N.L., Maldonado E.N., Kern M.J., Bhat N.R., Hama H.;
RT   "FA2H-dependent fatty acid 2-hydroxylation in postnatal mouse brain.";
RL   J. Lipid Res. 47:2772-2780(2006).
RN   [4]
RP   FUNCTION, INDUCTION, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, PATHWAY, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=17901466; DOI=10.1194/jlr.m700400-jlr200;
RA   Maldonado E.N., Alderson N.L., Monje P.V., Wood P.M., Hama H.;
RT   "FA2H is responsible for the formation of 2-hydroxy galactolipids in
RT   peripheral nervous system myelin.";
RL   J. Lipid Res. 49:153-161(2008).
CC   -!- FUNCTION: Catalyzes the hydroxylation of free fatty acids at the C-2
CC       position to produce 2-hydroxy fatty acids, which are building blocks of
CC       sphingolipids and glycosphingolipids common in neural tissue and
CC       epidermis (Probable). FA2H is stereospecific for the production of (R)-
CC       2-hydroxy fatty acids (By similarity). Plays an essential role in the
CC       synthesis of galactosphingolipids of the myelin sheath
CC       (PubMed:17901466). Responsible for the synthesis of sphingolipids and
CC       glycosphingolipids involved in the formation of epidermal lamellar
CC       bodies critical for skin permeability barrier (By similarity).
CC       Participates in the synthesis of glycosphingolipids and a fraction of
CC       type II wax diesters in sebaceous gland, specifically regulating hair
CC       follicle homeostasis. Involved in the synthesis of sphingolipids of
CC       plasma membrane rafts, controlling lipid raft mobility and trafficking
CC       of raft-associated proteins (By similarity).
CC       {ECO:0000250|UniProtKB:Q5MPP0, ECO:0000250|UniProtKB:Q7L5A8,
CC       ECO:0000269|PubMed:17901466, ECO:0000305|PubMed:17901466}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-saturated fatty acid + 2 Fe(II)-[cytochrome b5] + 2 H(+)
CC         + O2 = a (R)-2-hydroxy fatty acid + 2 Fe(III)-[cytochrome b5] + H2O;
CC         Xref=Rhea:RHEA:38855, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:76177,
CC         ChEBI:CHEBI:83955; Evidence={ECO:0000250|UniProtKB:Q7L5A8,
CC         ECO:0000305|PubMed:17901466};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38856;
CC         Evidence={ECO:0000250|UniProtKB:Q7L5A8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 Fe(II)-[cytochrome b5] + 2 H(+) + hexadecanoate + O2 = (R)-
CC         2-hydroxyhexadecanoate + 2 Fe(III)-[cytochrome b5] + H2O;
CC         Xref=Rhea:RHEA:38551, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:75927; Evidence={ECO:0000250|UniProtKB:Q7L5A8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38552;
CC         Evidence={ECO:0000250|UniProtKB:Q7L5A8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 + octadecanoate = (R)-
CC         2-hydroxyoctadecanoate + 2 Fe(III)-[cytochrome b5] + H2O;
CC         Xref=Rhea:RHEA:39815, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:25629, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:57562; Evidence={ECO:0000250|UniProtKB:Q7L5A8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39816;
CC         Evidence={ECO:0000250|UniProtKB:Q7L5A8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=docosanoate + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 = 2-
CC         hydroxydocosanoate + 2 Fe(III)-[cytochrome b5] + H2O;
CC         Xref=Rhea:RHEA:39819, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:23858, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:76722; Evidence={ECO:0000250|UniProtKB:Q7L5A8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39820;
CC         Evidence={ECO:0000250|UniProtKB:Q7L5A8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 + tetracosanoate = (R)-
CC         2-hydroxytetracosanoate + 2 Fe(III)-[cytochrome b5] + H2O;
CC         Xref=Rhea:RHEA:38559, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:31014,
CC         ChEBI:CHEBI:75935; Evidence={ECO:0000250|UniProtKB:Q7L5A8,
CC         ECO:0000305|PubMed:17901466};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38560;
CC         Evidence={ECO:0000250|UniProtKB:Q7L5A8, ECO:0000305|PubMed:17901466};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q03529};
CC       Note=Binds 2 Zn(2+) ions per subunit that likely form a catalytic
CC       dimetal center. {ECO:0000250|UniProtKB:Q03529};
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC       {ECO:0000269|PubMed:17901466}.
CC   -!- PATHWAY: Sphingolipid metabolism; galactosylceramide biosynthesis.
CC       {ECO:0000269|PubMed:17901466}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q7L5A8}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q7L5A8}. Microsome membrane
CC       {ECO:0000250|UniProtKB:Q7L5A8}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q7L5A8}.
CC   -!- TISSUE SPECIFICITY: Detected in oligodendrocytes (at protein level).
CC       Detected in sciatic nerve. {ECO:0000269|PubMed:16998236,
CC       ECO:0000269|PubMed:17901466}.
CC   -!- DEVELOPMENTAL STAGE: Detected at low levels in sciatic nerve from
CC       newborns. Levels increase strongly during the first 3 weeks, and
CC       decrease thereafter to reach a low, constitutive level in 4 week olds.
CC       Expressed at a low, constitutive level in adults.
CC       {ECO:0000269|PubMed:17901466}.
CC   -!- INDUCTION: Up-regulated in sciatic nerve during myelination. Up-
CC       regulated in differentiating cultured Schwann cells.
CC       {ECO:0000269|PubMed:17901466}.
CC   -!- DOMAIN: The histidine box domains may contain the active site and/or be
CC       involved in metal ion binding.
CC   -!- DOMAIN: The N-terminal cytochrome b5 heme-binding domain is essential
CC       for catalytic activity. {ECO:0000250|UniProtKB:Q7L5A8}.
CC   -!- SIMILARITY: Belongs to the sterol desaturase family. SCS7 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ339484; ABC71132.1; -; mRNA.
DR   EMBL; CO396956; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_001129055.1; NM_001135583.1.
DR   AlphaFoldDB; Q2LAM0; -.
DR   SMR; Q2LAM0; -.
DR   STRING; 10116.ENSRNOP00000025625; -.
DR   SwissLipids; SLP:000001975; -.
DR   PhosphoSitePlus; Q2LAM0; -.
DR   PaxDb; 10116-ENSRNOP00000025625; -.
DR   Ensembl; ENSRNOT00000025625.7; ENSRNOP00000025625.5; ENSRNOG00000018950.8.
DR   Ensembl; ENSRNOT00055034926; ENSRNOP00055028337; ENSRNOG00055020458.
DR   Ensembl; ENSRNOT00060019660; ENSRNOP00060015476; ENSRNOG00060011613.
DR   Ensembl; ENSRNOT00065020557; ENSRNOP00065015810; ENSRNOG00065012627.
DR   GeneID; 307855; -.
DR   KEGG; rno:307855; -.
DR   UCSC; RGD:1310347; rat.
DR   AGR; RGD:1310347; -.
DR   CTD; 79152; -.
DR   RGD; 1310347; Fa2h.
DR   eggNOG; KOG0537; Eukaryota.
DR   eggNOG; KOG0539; Eukaryota.
DR   GeneTree; ENSGT00390000002142; -.
DR   HOGENOM; CLU_034756_2_0_1; -.
DR   InParanoid; Q2LAM0; -.
DR   OMA; WTIIEYV; -.
DR   OrthoDB; 208810at2759; -.
DR   PhylomeDB; Q2LAM0; -.
DR   TreeFam; TF314955; -.
DR   Reactome; R-RNO-1660661; Sphingolipid de novo biosynthesis.
DR   UniPathway; UPA00199; -.
DR   UniPathway; UPA00787; -.
DR   PRO; PR:Q2LAM0; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000018950; Expressed in stomach and 9 other cell types or tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0080132; F:fatty acid alpha-hydroxylase activity; IMP:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0032286; P:central nervous system myelin maintenance; ISO:RGD.
DR   GO; GO:0046513; P:ceramide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0061436; P:establishment of skin barrier; ISS:UniProtKB.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006631; P:fatty acid metabolic process; ISO:RGD.
DR   GO; GO:0006682; P:galactosylceramide biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006679; P:glucosylceramide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0030258; P:lipid modification; ISO:RGD.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; ISO:RGD.
DR   GO; GO:0044857; P:plasma membrane raft organization; ISS:UniProtKB.
DR   GO; GO:1904697; P:regulation of acinar cell proliferation; ISO:RGD.
DR   GO; GO:0042634; P:regulation of hair cycle; ISO:RGD.
DR   GO; GO:1904002; P:regulation of sebum secreting cell proliferation; ISO:RGD.
DR   GO; GO:0001949; P:sebaceous gland cell differentiation; ISO:RGD.
DR   Gene3D; 3.10.120.10; Cytochrome b5-like heme/steroid binding domain; 1.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR018506; Cyt_B5_heme-BS.
DR   InterPro; IPR006694; Fatty_acid_hydroxylase.
DR   InterPro; IPR014430; Scs7.
DR   PANTHER; PTHR12863:SF1; FATTY ACID 2-HYDROXYLASE; 1.
DR   PANTHER; PTHR12863; FATTY ACID HYDROXYLASE; 1.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF04116; FA_hydroxylase; 1.
DR   PIRSF; PIRSF005149; IPC-B_HD; 1.
DR   PRINTS; PR00363; CYTOCHROMEB5.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; Cytochrome b5-like heme/steroid binding domain; 1.
DR   PROSITE; PS00191; CYTOCHROME_B5_1; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Heme; Iron; Lipid biosynthesis; Lipid metabolism; Membrane; Metal-binding;
KW   Microsome; Oxidoreductase; Reference proteome; Sphingolipid metabolism;
KW   Transmembrane; Transmembrane helix; Zinc.
FT   CHAIN           1..372
FT                   /note="Fatty acid 2-hydroxylase"
FT                   /id="PRO_0000312352"
FT   TRANSMEM        168..188
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        213..233
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        268..288
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        290..310
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          8..86
FT                   /note="Cytochrome b5 heme-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   DOMAIN          219..361
FT                   /note="Fatty acid hydroxylase"
FT                   /evidence="ECO:0000255"
FT   BINDING         43
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   BINDING         69
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   BINDING         234
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         239
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         257
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         260
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         261
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         315
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         319
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         336
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         339
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
FT   BINDING         340
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q03529"
SQ   SEQUENCE   372 AA;  42673 MW;  AC02C568DF1BF7A6 CRC64;
     MAPAPPPAAS FTSAEVQRRL AAGACWVRRG ASLYDLTGFV RHHPGGEQLL LARAGQDISA
     DLDGPPHKHS DNARRWLEQY YVGELRADPQ DPTENGAGAP AETQKTDAAI EPQFKVVDWD
     KDLVDWQKPL LWQVGHLGEK YDEWVHQPVA RPIRLFHSDL IEAFSKTVWY SVPIIWVPLV
     LYLSWSYYRT LTQDNIRLFA SFTRDYSLVV PESVFIGLFV LGMLIWTLVE YLIHRFLFHM
     KPPSNSHYLI MLHFVMHGQH HKAPFDGSRL VFPPVPASVV VAFFYVFLRL ILPEAVAGIL
     FAGGLLGYVL YDMTHYYLHF GSPHKGSYLY NMKAHHVKHH FEYQKSGFGI STKLWDYFFH
     TLIPEEADPK MQ
//
